Behavioural science, and the changes it can bring to patient and healthcare provider behaviour, has important implications for pharmaceutical companies and health systems alike.
In an ambitious move, Moderna has teamed up with OpenAI, the artificial intelligence company behind ChatGPT, to furthe
Explore “Innovation as Strategy” framework, providing a guide for employing innovative strategies in life sciences.
In this edition of Deep Dive, Unpacking complex choreography in the biologics patent dance, Alexion examines the urgent need for accelerated access programmes for rare disease treatments, and Putna
It will come as no surprise to anyone in the healthcare space that doctors today are under an inordinate amount of pressure.
We are living in an era of unprecedented advances in cancer treatments with transformative therapies being regularly approved.
The Home of Accelerating Microbial-Based Drug Development
The PM Society is a not-for-profit organisation with 40 years of Giving Back.
